A detailed history of International Biotechnology Trust PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, International Biotechnology Trust PLC holds 38,000 shares of LEGN stock, worth $1.53 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
38,000
Previous 38,000 -0.0%
Holding current value
$1.53 Million
Previous $2.62 Million 2.71%
% of portfolio
0.87%
Previous 0.82%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$38.15 - $57.1 $1.44 Million - $2.16 Million
37,752 Added 15222.58%
38,000 $1.55 Million
Q2 2022

Aug 16, 2022

SELL
$33.54 - $55.0 $142,612 - $233,860
-4,252 Reduced 94.49%
248 $4.5 Million
Q4 2021

Feb 15, 2022

SELL
$41.14 - $56.98 $1.85 Million - $2.56 Million
-45,000 Reduced 90.91%
4,500 $209,000
Q3 2021

Nov 12, 2021

BUY
$35.31 - $50.56 $1.75 Million - $2.5 Million
49,500 New
49,500 $2.5 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.